The abstract is read at the publisher; the summary is JClub's.
CSTPP, a cardiomyocyte-specific lncRNA, extends the cardiomyocyte cell-cycle activation window after myocardial infarction by promoting CDKN1A mRNA decay via YBX1–UPF1.
- Why it matters: Adult cardiomyocytes rapidly rearrest the cell cycle after activation, limiting regeneration after MI; the lncRNA mechanisms controlling this rearrest are unclear.
- What they did: Bulk RNA-seq identified CSTPP as downregulated after injury; gain- and loss-of-function in neonatal rat ventricular myocytes and post-MI models tested proliferation and cardiac function, with RNA pulldown/immunoprecipitation mapping CSTPP–YBX1–UPF1–CDKN1A regulation.
- The result: CSTPP overexpression increased proliferation and improved post-MI cardiac function, while CSTPP deletion reduced proliferation and worsened dysfunction; CSTPP also reduced CDKN1A in human iPSC-derived cardiomyocytes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.